S. Gadalla

First name
S.
Middle name
M.
Last name
Gadalla
Brown, J., Pfeiffer, R. M., Shrewsbury, D., O'Callaghan, S., Berner, A. M., Gadalla, S. M., et al. (2023). Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data. Br J Gen Pract. http://doi.org/10.3399/bjgp.2023.0023
View
Jackson, S. S., Brown, J., Pfeiffer, R. M., Shrewsbury, D., O'Callaghan, S., Berner, A. M., et al. (2023). Analysis of Mortality Among Transgender and Gender Diverse Adults in England. Jama Netw Open, 6, e2253687. http://doi.org/10.1001/jamanetworkopen.2022.53687
View
Liu, Z., Alsaggaf, R., McGlynn, K. A., Anderson, L. A., Tsai, H. T., Zhu, B., et al. (2018). Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink. Gut. http://doi.org/10.1136/gutjnl-2018-317504
View
Karimi, P., Birmann, B. M., Anderson, L. A., McShane, C. M., Gadalla, S. M., Sampson, J. N., & Mbulaiteye, S. M. (2018). Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink. Br J Haematol. http://doi.org/10.1111/bjh.15229
View
Wang, Y., Pfeiffer, R. M., Alsaggaf, R., Meeraus, W., Gage, J. C., Anderson, L. A., et al. (2018). Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink. Int J Cancer. http://doi.org/10.1002/ijc.31143
View
Wolfson, D. B., Best, A. F., Addona, V., Wolfson, J., & Gadalla, S. M. (2018). Benefits of combining prevalent and incident cohorts: An application to myotonic dystrophy. Stat Methods Med Res. http://doi.org/10.1177/0962280218804275
View
Alsaggaf, R., St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Wagner, K. R., et al. (2018). Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity. JNCI Cancer Spectr. http://doi.org/10.1093/jncics/pky052
View
Alsaggaf, R., Pfeiffer, R. M., Wang, Y., St George, D. M. M., Zhan, M., Wagner, K. R., et al. (2019). Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I. Int J Cancer. http://doi.org/10.1002/ijc.32801
View
Alsaggaf, R., St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Anderson, L. A., et al. (2019). Benign tumors in myotonic dystrophy type I target disease-related cancer sites. Ann Clin Transl Neurol. http://doi.org/10.1002/acn3.50856
View
Jackson, S. S., Pfeiffer, R. M., Gabbi, C., Anderson, L., Gadalla, S. M., & Koshiol, J. (2021). Menopausal hormone therapy and risk of biliary tract cancers. Hepatology. http://doi.org/10.1002/hep.32198
View